An announcement from Argent Biopharma ( (AU:RGT) ) is now available.
Argent Biopharma Limited announced the issuance of 2,500,000 ordinary fully paid shares, following approval at the company’s general meeting. This move is expected to enhance the company’s capital base, potentially strengthening its market position and providing additional resources for ongoing projects.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies. The company is committed to advancing healthcare solutions through its research and development efforts.
YTD Price Performance: -20.83%
Average Trading Volume: 554
Technical Sentiment Signal: Buy
Current Market Cap: $6.82M
See more data about RGT stock on TipRanks’ Stock Analysis page.